首页> 外文期刊>Scientific reports. >Cellular and molecular mechanisms associated with ischemic stroke severity in female mice with chronic kidney disease
【24h】

Cellular and molecular mechanisms associated with ischemic stroke severity in female mice with chronic kidney disease

机译:慢性肾脏病雌性小鼠缺血性卒中严重程度的细胞和分子机制

获取原文
           

摘要

Ischemic stroke is highly prevalent in chronic kidney disease (CKD) patients and has been associated with a higher risk of neurological deterioration and in-hospital mortality. To date, little is known about the processes by which CKD worsens ischemic stroke. This work aimed to investigate the cellular and molecular mechanism associated with ischemic stroke severity in an in vivo model of CKD. CKD was induced through right kidney cortical electrocautery in 8-week-old female C57BL/6?J mice followed by left total nephrectomy. Transient middle cerebral artery occlusion (tMCAO) was performed 6 weeks after left nephrectomy. Twenty-four hours after tMCAO, the infarct volumes were significantly wider in CKD than in SHAM mice. CKD mice displayed decreased neuroscore, impaired ability to remain on rotarod device, weaker muscular strength and decreased prehensile score. Apoptosis, neuronal loss, glial cells recruitment and microglia/macrophages Msub1/sub signature genes CD32, CD86, IL-1β, IL-6, MCP1 and iNOS were significantly increased within ischemic lesions of CKD mice. This effect was associated with decreased AMP kinase phosphorylation and increased activation of the NFΚB pathway. Pharmacological targeting of AMP kinase activity, which is known to block microglia/macrophages Msub1/sub polarization, appears promising to improve stroke recovery in CKD.
机译:缺血性中风在慢性肾脏病(CKD)患者中非常普遍,并且与神经系统恶化和医院内死亡的较高风险相关。迄今为止,关于CKD加重缺血性中风的过程知之甚少。这项工作旨在研究与CKD体内模型中缺血性卒中严重程度相关的细胞和分子机制。 CKD是在8周龄雌性C57BL / 6?J小鼠中通过右肾皮质电灼诱导的,然后进行左全肾切除术。左肾切除术后6周进行短暂性大脑中动脉闭塞(tMCAO)。 tMCAO后二十四小时,CKD的梗死体积明显比SHAM小鼠大。 CKD小鼠表现出神经评分降低,保持在旋转脚架设备上的能力受损,肌肉力量减弱和综合评分降低。细胞凋亡,神经元丢失,神经胶质细胞募集和小胶质细胞/巨噬细胞M 1 签名基因CD32,CD86,IL-1β,IL-6,MCP1和iNOS在CKD小鼠的缺血性损伤中显着增加。该作用与降低的AMP激酶磷酸化和增加的NFκB途径活化有关。 AMP激酶活性的药理靶向作用可阻止小胶质细胞/巨噬细胞M 1 极化,这有望改善CKD的卒中恢复。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号